The IL-6/STAT3 signaling pathway is an early target of manuka honey-induced suppression of human breast cancer cells

Priyanka Aryappalli, Sarah S. Al-Qubaisi, Samir Attoub, Junu A. George, Kholoud Arafat, Khalil B. Ramadi, Yassir A. Mohamed, Mezoon M. Al-Dhaheri, Ashraf Al-Sbiei, Maria J. Fernandez-Cabezudo, Basel K. Al-Ramadi

    Research output: Contribution to journalArticlepeer-review

    Abstract

    There is renewed interest in the potential use of natural compounds in cancer therapy. Previously, we demonstrated the anti-tumor properties of manuka honey (MH) against several cancers. However, the underlying mechanism and molecular targets of this activity remain unknown. For this study, the early targets of MH and its modulatory effects on proliferation, invasiveness, and angiogenic potential were investigated using two human breast cancer cell lines, the triple-negative MDA-MB-231 cells and estrogen receptor-positive MCF-7 cells, and the non-neoplastic breast epithelial MCF-10A cell line. Exposure to MH at concentrations of 0.3-1.25% (w/v) induced a dose-dependent inhibition of the proliferation of MDA-MB-231 and MCF-7, but not MCF-10A, cells. This inhibition was independent of the sugar content of MH as a solution containing equivalent concentrations of its three major sugars failed to inhibit cell proliferation. At higher concentrations ( > 2.5%), MH was found to be generally deleterious to the growth of all three cell lines. MH induced apoptosis of MDA-MB-231 cells through activation of caspases 8, 9, 6, and 3/7 and this correlated with a loss of Bcl-2 and increased Bax protein expression in MH-treated cells. Incubation with MH induced a time-dependent translocation of cytochrome c from mitochondria to the cytosol and Bax translocation from the cytosol into the mitochondria. MH also induced apoptosis of MCF-7 cells via the activation of caspases 9 and 6. Low concentrations of MH (0.03-1.25% w/v) induced a rapid reduction in tyrosine-phosphorylated STAT3 (pY-STAT3) in MDA-MB-231 and MCF-7 cells. Maximum inhibition of pY-STAT3 was observed at 1 h with a loss of > 80% and coincided with decreased interleukin-6 (IL-6) production. Moreover, MH inhibited the migration and invasion of MDA-MB-231 cells as well as the angiogenic capacity of human umbilical vein endothelial cells. Our findings identify multiple functional pathways affected by MH in human breast cancer and highlight the IL-6/STAT3 signaling pathway as one of the earliest potential targets in this process.

    Original languageEnglish (US)
    Article number167
    JournalFrontiers in Oncology
    Volume7
    Issue numberAUG
    DOIs
    StatePublished - Aug 14 2017

    Keywords

    • Apoptosis
    • Interleukin-6
    • Manuka honey
    • STAT3
    • Triple-negative breast cancer

    ASJC Scopus subject areas

    • Oncology
    • Cancer Research

    Fingerprint Dive into the research topics of 'The IL-6/STAT3 signaling pathway is an early target of manuka honey-induced suppression of human breast cancer cells'. Together they form a unique fingerprint.

    Cite this